http://www.onemedplace.com/blog/wp-content/uploads/2009/11/diabetes.jpg
The approval of Novo Nordisk's diabetes drug Victoza has led to an unintended benefit for a competitor.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/03/pills_credit_card.jpg
Delcath's Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient's entire body...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/04/assorted-capsules.jpg
Last week, the FDA unveiled its "Bad Ad" program to encourage physicians to report questionable pharmaceutical sales pitches.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/05/test_tubes.jpg
One of the more impressive companies at the IN3 West conference was Altea Therapeutics, an Atlanta-based clinical stage company involved in drug delivery.
View Article
More Pages to Explore .....